Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / SHS USD
-
Number of holders
-
317
-
Total 13F shares, excl. options
-
53.4M
-
Shares change
-
-145K
-
Total reported value, excl. options
-
$6.48B
-
Value change
-
-$52.5M
-
Put/Call ratio
-
1.99
-
Number of buys
-
142
-
Number of sells
-
-197
-
Price
-
$121.48
Significant Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q3 2016
415 filings reported holding JAZZ - Jazz Pharmaceuticals plc - SHS USD as of Q3 2016.
Jazz Pharmaceuticals plc - SHS USD (JAZZ) has 317 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53.4M shares
.
Largest 10 shareholders include FMR LLC (8.76M shares), PUTNAM INVESTMENTS LLC (7.56M shares), VANGUARD GROUP INC (4.29M shares), FIL Ltd (1.8M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (1.64M shares), CADIAN CAPITAL MANAGEMENT, LP (1.31M shares), Bank of New York Mellon Corp (1.17M shares), Partner Fund Management, L.P. (1.16M shares), BlackRock Institutional Trust Company, N.A. (1.06M shares), and BlackRock Fund Advisors (1.05M shares).
This table shows the top 317 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.